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Molecular Stenting with a Crosslinked Hyaluronan
Derivative Inhibits Collagen Gel Contraction
Tanuj D. Mehra1,5, Kaustabh Ghosh1,5, Xiao Zheng Shu2, Glenn D. Prestwich2 and Richard A.F. Clark1,3,4
Adult burn wounds, which lack hyaluronan (HA), often undergo excessive tissue remodeling and contraction. In
contrast fetal wounds, which contain large amounts of HA, undergo remodeling that culminates in a scarless
repair or regeneration. Therefore, adding a HA derivative to burn wounds would better mimic the fetal
extracellular matrix and could reduce contraction. To test this hypothesis, we determined the effects of HA and
its two derivatives on fibroblast-mediated, collagen gel contraction, an assay widely used to mimic in vivo
wound contraction. Interestingly, high molecular weight HA (HMW HA) facilitated collagen gel contraction,
whereas a thiol-functionalized derivative HA-DTPH weakly inhibited contraction. In contrast, polyethylene
glycol diacrylate (PEGDA)-crosslinked HA-DTPH (HA-DTPH-PEGDA) strongly inhibited contraction in a
concentration-dependent manner. Immunofluorescence staining of cellular actin showed that this inhibition
was not owing to reduced cell attachment or spreading. Furthermore, the supernatant of contracted collagen-
HMW HA gels contained greater amounts of HA than those found in the supernatant of collagen-HA-DTPH-
PEGDA gels, suggesting that HMW HA facilitates contraction by effectively diffusing out of the collagen gels.
Therefore, the results suggest that the crosslinking of HA-DTPH enhances the structural mechanics of collagen/
HA-DTPH composites, which resists the fibroblast contractile forces and may, therefore, be able to reduce
excessive wound contraction observed in pathological conditions.
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INTRODUCTION
During remodeling of a normally healing wound, myofibro-
blasts contract the wound edges by attaching to and pulling
on the underlying collagen-rich matrix (Gabbiani et al., 1971,
1976). The compacted collagen fibers form intermolecular
crosslinks resulting in the formation of straighter collagen
bundles (clinically called ‘‘scar’’) than the basket-woven
array of normal dermis. Unlike normal wounds where
contraction ceases following myofibroblast apoptosis
(Gabbiani, 2003; Grinnell, 2003), burn wounds experience
prolonged scar contraction owing to the continuous synthesis
of collagen and its subsequent contraction by long-lived
myofibroblasts, thereby leading to the formation of contrac-
tures (Grinnell, 1994). Any biocompatible process or material
that can prevent excessive collagen contraction would hold
tremendous promise for the improved treatment of burn
wounds with decrease or elimination of contractures.
Previous studies comparing normal adult and fetal wound
healing processes have suggested that hyaluronan (HA) has a
critical role in the regeneration or scarless repair of
embryonic wounds (Longaker et al., 1989, 1991). HA is a
naturally occurring, polyanionic, non-sulfated glycosamino-
glycan composed of repeating disaccharide units of (a-1,4-D-
glucuronic acid and b-1,3-N-acetyl-D-glucosamine) (Burd
et al., 1989). It occurs naturally in a wide range of MWs
(MWs, 0.1–10 million Daltons) and concentrations, where the
highest amount is found in skin tissue, which is approxi-
mately 50% of the total HA present in the body. In vivo, HA is
stabilized by numerous link proteins (Hardingham and
Fosang, 1992). During both adult and embryonic wound
healing, HA levels increase in concert with granulation tissue
formation where it promotes cell migration and proliferation
(Chen and Abatangelo, 1999). While HA levels in normal
adult wounds fall with the maturation of granulation tissue
and initiation of the subsequent remodeling phase, they
remain consistently elevated in fetal wounds (Longaker et al.,
1990). Therefore, increased and prolonged presence of HA in
adult wounds may modulate the synthesis and organization
of collagen fibers in a manner that resembles fetal wound
healing.
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An in vitro collagen gel contraction assay (Bell et al.,
1979, 1983) simulates in vivo wound contraction. This model
was subsequently used to elucidate the role of HA in
modulating fibroblast contraction of collagen gels (Travis
et al., 2001). Surprisingly, HA was found to enhance collagen
contraction in vitro, with the degree of contraction scaling
linearly with HA concentration. This finding was counter-
intuitive from the prediction that HA might inhibit collagen
contraction. However, native HA normally resides in con-
junction with versican, an aggregating chondroitin sulfate
proteoglycan that interacts with and stabilizes HA via link
proteins (Sorrell et al., 1999). The association of versican may
be critical for the inhibitory effect of HA on wound
contraction.
Consequently, in this study, we aimed to mimic the in vivo
versican-mediated stability of HA via inter-molecular cross-
linking of exogenous HA and investigate the effect on
fibroblast contraction of collagen gels. Thiol-functionalized
HA (HA-DTPH) (Shu et al., 2002) was added to collagen gels
either directly or after crosslinking with poly(ethylene glycol)
diacrylate (PEGDA) (Shu et al., 2004), and its effect on gel
contraction monitored. As the stability of a crosslinked
network is known to depend not only on the MW and
concentration of the macromer but also on the nature and
density of effective crosslinks (Anseth et al., 1996), we altered
both the concentration and MW of the PEGDA crosslinker to
study their effect on gel contraction. For comparison, native
high molecular weight HA (HMW HA) was also separately
added to gels and the corresponding contraction monitored.
Cellular F-actin cytoskeleton was stained and visualized to
determine and compare fibroblast morphology in the
collagen or composite gels. As a further step towards
understanding the mechanism of fibroblast-mediated con-
traction of these HA-collagen gels, the supernatant of
contracted gels were evaluated for levels of HA released
during gel contraction.
RESULTS
Dose response of PDGF on fibroblast-mediated collagen gel
contraction
As reported previously, platelet-derived growth factor (PDGF)
stimulated the contraction of fibroblast-populated collagen
gels (Bell et al., 1979, 1983). The gel diameters were
measured at various time points and were plotted over a
48-hour period (Figure 1). As expected, the fibroblast-
mediated collagen gel contraction occured in a PDGF
dose-dependent manner with maximal contraction for
100 ng/ml PDGF and almost no contraction for the 0 ng/ml
PDGF. Experiments were performed (data not shown) where
the dose was increased to 300 ng/ml. The contraction of the
gels reached a plateau at 100 ng/ml and increasing the dose
beyond this concentration did not show any difference in
contraction.
Effect of HMW and low molecular weight HA on collagen gel
contraction
HMW HA facilitated contraction of collagen gel as reported
previously (Travis et al., 2001). Gel contraction increased
with increasing concentration of HMW HA (Figure 2b),
where the differences in final contraction between HMW
HA concentrations were statistically significant (Po0.05).
Contraction indices were 2.04 and 3.56 for 0.12 and 0.25%
HA, respectively. Low MW HA, however, failed to show
any significant effect (P40.05) on collagen gel contraction
(Figure 2).
HA-DTPH inhibited collagen gel contraction
HA-DTPH alone inhibited contraction of collagen gels. Gel
contraction decreased with increasing concentration of HA-
DTPH (Figure 2c), where the differences in final contraction
between various HA-DTPH concentrations were statistically
significant (Po0.05). Contraction Indices were 2.32 and
10.61 for 0.12 and 0.25% HA-DTPH, respectively. This
inhibitory effect is not owing to any cytotoxic effects, as HA-
DTPH has already been shown to be completely biocompa-
tible (Shu et al., 2002; Liu et al., 2005). This inhibition is
likely caused by the formation of spontaneous, albeit slow,
disulfide bonds that result from the air oxidation of free thiol
groups on HA-DTPH. These disulfide bonds are irreversible
in air and have been shown to crosslink a 1% HA-DTPH
solution in approximately 4–6 hours (Shu et al., 2002; Ghosh
et al., 2005).
HA-DTPH-PEGDA inhibited collagen gel contraction
Altering PEGDA concentration (MW fixed at 3400 Da).
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Figure 1. Dose response of PDGF on fibroblast-mediated collagen gel
contraction.
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Figure 2. Effect of different forms of HA on collagen gel contraction.
Contraction of the collagen gels is expressed as a difference in initial area (A0)
at t¼ 0 and final area (A1) at t¼ 48 hours. Contraction indices for (a) low MW
H were 0.35 and 0 for 0.12 and 0.25% HA (w/v) respectively; (b) HMW HA
were 2.04 and 3.56 for 0.12 and 0.25% HA (w/v) respectively; and
(c) HA-DTPH were 2.32 and 10.61 for 0.12 and 0.25% HA (w/v),
respectively.
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of different crosslinking densities (2:1, 6:1, and 12:1) were
mixed with collagen and allowed to gel in the presence of
adult human dermal fibroblasts (AHDFs). All gels containing
HA-DTPH-PEGDA showed a significant inhibition when
compared with the controls (Figure 3), with the degree of
inhibition increasing linearly with both HA-DTPH and
PEGDA concentration. The contraction index varied signifi-
cantly as the crosslinked ratio was altered (Table 1). Similar to
HA-DTPH, the HA-DTPH-PEGDA solutions have also been
shown to be completely cytocompatible before (Ghosh et al.,
2006). Gel contraction was compared in two ways: (a)
between different HA-DTPH concentrations at each cross-
linking density and (b) between different crosslinking
densities at each HA-DTPH concentration. In both cases,
the differences in gel contraction were found to be
statistically significant (Po0.05). Table 1 shows the values
of contraction indices obtained for the different concentra-
tions and crosslinking ratios.
Altering PEGDA MW (crosslinking density fixed at 2:1).
PEGDA with three different MWs (3400, 700, 258 Da) were
used to prepare HA-DTPH-PEGDA constructs with a cross-
linking density of 2:1 (Figure 4). The contraction index did
not change substantially with a change in PEGDA MW
(Table 2), although the inhibition was significant (Po0.05)
when compared with the control. In addition, for each MW of
PEGDA, the difference in inhibition of gel contraction was
statistically significant between different concentrations of
HA-DTPH (Po0.05).
Temporal progression of composite gel contraction. Figure 5
shows the time course of the contraction of various
composite gels. All HA-DTPH additives demonstrated an
inhibitory effect right from the commencement of gel
contraction, with the 0.25% HA-DTPH-PEGDA additive
producing both the maximal and the fastest inhibition.
Importantly, all but control collagen gels attained the
terminally contracted state within 20 hours, indicating the
stable nature of the crosslinked HA-DTPH network formed
within the composite gels.
Fibroblast morphology
To determine whether the inhibition in gel contraction was
caused by reduced cell attachment or spreading, we stained
and visualized the fibroblast-populated gels at 4 and 24 hours
post-contraction. As Figure 6 shows, fibroblast attachment
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Figure 3. Effect of HA-DTPH-PEGDA (PEGDA MW 3400 Da) crosslinking
density on collagen gel contraction. HA-DTPH-PEGDA constructs were
prepared at crosslinking densities of 2:1, 6:1, and 12:1. (a) Images of
the collagen/HA-DTPH-PEGDA composites at 48 hours post-contraction,
(b) quantification of gel areas – refer to Table 1 for contraction indices.
Table 1. Inhibition of collagen gel contraction by
crosslinked HA hydrogels as a function of crosslinking
density (PEGDA concentraction)
Ratio (free thiols
to PEGDA
double bonds)
Concentration
HA-DTPH-PEGDA
(wt/vol) (%)
Contraction
index
2:1 0.12 11.08
2:1 0.25 47.98
6:1 0.12 2.32
6:1 0.25 17.25
12:1 0.12 2.32
12:1 0.25 11.57
Table 2. Inhibition of collagen gel contraction by
crosslinked HA hydrogels as a function of PEGDA
molecular weight
MW of PEGDA
Concentration
HA-DTPH-PEGDA
(wt/vol) (%)
Contraction
index
258 0.12 3.35
258 0.25 43.37
700 0.12 8.15
700 0.25 46.48
3400 0.12 9.04
3400 0.25 59.2
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Figure 4. Effect of PEGDA MWs on collagen gel contraction.
HA-DTPH-PEGDA constructs were prepared using PEGDA MWs 258,
700, and 3400 Da, while fixing the crosslinking density at 2:1.
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and spreading within collagen/HA-DTPH-PEGDA gels was
similar to that within the control collagen gels at both time
points. Furthermore, these images clearly demonstrate
the inhibition in contraction of collagen/HA-DTPH-PEGDA
gels as the average cell density per unit volume did not
significantly change with incubation time. Fibroblast density
within the control collagen gels, however, increased
dramatically, which would be expected in a contracted
collagen gel.
HA released into the supernatant during gel contraction
The amount of free HA in the supernatant of the collagen/
collagen-HA composite gels was quantitatively measured.
Results (shown in Figure 7) indicate that the highest levels of
HA were detected in gels receiving HMW HA, which was
significantly higher than that observed in gels receiving either
HA-DTPH or HA-DTPH-PEGDA. Although the level of
supernatant HA was not statistically different for different
HA concentrations (0.125 and 0.25%) within the same
collagen-HA composite, the difference was significant
(Po0.05) when different composites were compared at the
same concentration. The experiment was performed in
triplicates.
DISCUSSION
Apart from having a profound influence on cell behavior
(Brecht et al., 1986), HA also plays an important role in the
structural characteristics of different tissues (Camenisch and
McDonald, 2000). From the perspective of extracellular
matrix (ECM) remodeling, native HMW HA has been shown
to facilitate collagen contraction by smooth muscle cells and
adventitial fibroblasts in vitro (Travis et al., 2001). It was
speculated that this facilitation in contraction was owing to
the increased interaction of cells with collagen resulting from
the HA-CD44 binding and the subsequent chaperoning of
collagen to the cell surface during cell internalization of
native HMW HA. In this report, we investigated whether
AHDFs contracted collagen-HA composites in a similar
manner. In addition, we looked at the effect of adding two
chemically modified derivatives of HA viz. HA-DTPH and
the crosslinked HA-DTPH-PEGDA on the AHDF-mediated
contraction of collagen gels.
Adding HMW HA to collagen gels produced results similar
to those reported previously (Travis et al., 2001), where
increasing HA concentration enhanced collagen gel contrac-
tion. This effect is attributed to the phenomenon called
‘‘reptation’’. Interestingly, both HA-DTPH and HA-DTPH-
PEGDA inhibited collagen contraction, in a process that we
call ‘‘molecular stenting’’, or ‘‘nanostenting’’. This finding
might potentially lead to the treatment of pathological
conditions (e.g. contractures) that involve excessive collagen
contraction and remodeling.
The presence of HA in tissues stabilizes and is stabilized
by other ECM components. In cartilage, for example, the
aggrecan–HA linkage is crucial for HA stabilization and
providing structural stability and rigidity to the native ECM
(Hardingham, 1981). Versican is another aggregating pro-
teoglycan found in many soft connective tissues, including
the dermis, (Hardingham, 1981) that aggregates with HA and
retains it in tissues through complex interactions involving
fibronectin and collagen (Sorrell et al., 1999). In fact, versican
is present in much larger quantities in the ECM of fetal skin as
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compared to adult skin (Sorrell et al., 1999) where it functions
to interact with and stabilize HA (Yamagata et al., 1986;
Sorrell et al., 1999). Since the scarless or minimally scarred
healing of fetal wounds, unlike adult wounds, is associated
with consistently elevated levels of HA, we believe that
versican’s role in retaining HA within the cutaneous ECM is
pivotal in guiding the remodeling of wound ECM in a manner
reminiscent of regeneration. Presumably, both aggrecan and
versican stabilize HA by acting as spacers or ‘‘stents’’,
thereby providing HA with a structural support. Development
of an HA-based biomaterial that can produce a similar effect
during adult wound healing would, therefore, be greatly
beneficial in preventing excessive or disorderly collagen
remodeling as observed in pathological conditions following
burn injuries.
In this report, we show that the application of crosslinked
HA derivative prevents excessive collagen contraction in
vitro. The global aim is to mimic the above-mentioned
aggrecan- and versican-mediated stability of HA in native
ECM by adding HA-DTPH, with or without PEGDA, to the
collagen gels and investigating their fibroblast-mediated
contraction. We hypothesized that both the spontaneous
and the PEGDA-crosslinking of HA-DTPH would enhance
the structural mechanics of the HA network in a way seen in
the versican-rich fetal ECM. This hypothesis was validated by
studies showing reduced levels of fibroblast-mediated
collagen gel contraction that contained either HA-DTPH or
HA-DTPH-PEGDA. Neither HA-DPTH nor PEGDA had any
adverse effects on fibroblast attachment and spreading as
judged by the immunoflourescence staining of cellular
F-actin. The similar nature of fibroblast morphology in both
collagen and collagen/HA-DTPH-PEGDA gels indicates that
the magnitude of contractile forces would probably be
similar. Hence, these findings strongly suggest that this
marked inhibition in gel contraction results from a greater
viscoelastic resistance produced by the more crosslinked HA-
DTPH-PEGDA network, which is less pronounced in the
disulfide-crosslinked network as shown in our previous
rheological studies (Ghosh et al., 2005). These data also
correlate well with our understanding that both aggrecan and
versican function by imparting greater structural stability to
the HA network, which then manifests itself in the observed
remodeling response.
Within the concentration range of 0.04–0.5%, HMW HA
(1 MDa) shows concentration-dependent self-diffusion,
which corresponds to the predicted behavior of polymer
entanglement (Gribbon and Hardingham, 1981, 2000).
Another study (Gribbon et al., 1999) showed that the self-
diffusion coefficient of HA decreases with an increase in
concentration. Based on the fluorescence recovery after
photobleaching analysis discussed in the latter report, we can
safely assume that self-diffusion of HA chains did occur at the
concentrations used in this study (0.12 and 0.25%). This, we
hypothesized, would cause HMW HA to slither and
ultimately diffuse out of the collagen matrix. If this were
true, higher levels of HA would be present in the supernatant
of collagen-HMW HA gels than those in the supernatant of
either collagen-HA-DTPH or collagen-HA-DTPH-PEGDA
gels. This was confirmed using the HA-ELISA kit that showed
that at 48 hours post-contraction, levels of HA were greater in
gels containing HMW HA as compared to those in gels
containing HA-DTPH additives. This suggests that both
spontaneous disulfide-crosslinking and PEGDA-crosslinking
introduce ‘‘nanostents’’ within the HA network, similar to
those produced by aggrecan and versican in native ECM, and
enhance the structural stability and viscoelastic properties of
the collagen gels. This, in turn, generates resistance to the
fibroblast-generated contractile forces. This inhibition of gel
contraction is not caused by the difference in MWs between
native HMW HA and HA-DTPH since lower MW non-
functionalized HA did not affect collagen gel contraction in
any way.
We argued that if the inhibition in gel contraction is
caused primarily owing to the intramolecular crosslinking of
HA-DTPH/HA-DTPH-PEGDA network, the inhibitory effect
should closely follow their crosslinking kinetics. Indeed, the
inhibition trend observed during the temporal progression of
gel contraction correlated inversely with the estimated
crosslinking kinetics (Ghosh et al., 2005) of the respective
HA-DTPH derivatives. For instance, HA-DTPH, which takes
B4–6 hours to crosslink spontaneously, produced a signifi-
cantly slower and weaker inhibition than HA-DTPH-PEGDA,
which takes B10 minutes to crosslink. In addition, the
inhibitory effect increased linearly with PEGDA (crosslinker)
concentration, which lends further support to our assumption
that inhibition is governed by the formation of a crosslinked
network, the viscoelasticity of which is primarily controlled
by the number of PEGDA-crosslinked junctions.
The effect of different PEGDA MWs (3400, 700, 258 Da)
on contraction of collagen gels was also evaluated. No
significant difference was observed in the extent of contrac-
tion. Even PEGDA of lower MWs (700 and 258 Da)
demonstrated a very strong inhibitory effect. This shows that
the inhibition in gel contraction is mainly dependent on the
concentration, and not the MW, of PEGDA. This finding is
consistent with the results from our recent rheological studies
that have shown that the bulk mechanical properties of HA-
DTPH-PEGDA hydrogels scale linearly with PEGDA con-
centration but are independent of its MW (Ghosh et al.,
2005). The same study also demonstrated the weak nature of
the spontaneously disulfide-bond crosslinked HA-DTPH net-
work. These results substantiate our current results where
HA-DTPH additives produced a weaker inhibition when
compared to HA-DTPH-PEGDA additives.
Although additional in vitro and in vivo studies need to be
conducted to fully realize the potential of HA-DTPH-PEGDA
biomaterials in preventing excessive collagen contraction in
patients with burns, we believe that this study will act as an
excellent platform to launch such experimentation.
MATERIALS AND METHODS
Cell culture
Primary AHDFs were obtained from Clonetics (San Diego, CA) and
used between passages 5 and 13. The cells were routinely cultured
in DMEM (Sigma) supplemented with 10% fetal bovine serum
(HyClone, Logan, UT) and an antibiotic (Gibco BRL, Grand Island,
2206 Journal of Investigative Dermatology (2006), Volume 126
TD Mehra et al.
Crosslinked HA Inhibits Collagen Contraction
NE) mix of penicillin, streptomycin, and L-glutamine, in a 371C, 5%
CO2/95% humidity incubator (Napco Scientific Company, Tualatin,
OR). Regardless of the functional assay, the AHDF monolayers were
grown to nearly 80% confluence, harvested, then centrifuged to
obtain a pellet that was rinsed twice with serum-free DMEMþ 2%
bovine serum albumin (fraction V, ICN Biomedicals, CT), and finally
resuspended in serum-free DMEM or DMEM supplemented with
10% fetal bovine serum and an antibiotic mix of penicillin,
streptomycin, and L-glutamine for use in functional assays.
HA-DTPH
HA-DTPH (Figure 8a) was synthesized as described previously (Shu
et al., 2002). Both the degree of substitution and the free thiol
content of HA-DTPH (determined by nuclear magnetic resonance
and modified Ellman’s method, respectively) were found to be
approximately 42%, indicating that the remaining 58% of the HA
disaccharide units contained the native carboxylic acid group.
Specimen preparation
Fibroblast-populated collagen gels. Fibroblasts were re-sus-
pended at a concentration of 1.5 106 cells/ml and mixed with
neutralized bovine skin collagen (Vitrogen, Collagen Corp., Paolo
Alto, CA), serum, and concentrated DMEM to obtain the final
concentrations of 1.8 mg/ml, 5%, and 1 , respectively. Human
plasma fibronectin (Chemicon International Inc., Temecula, CA) and
PDGF-BB (Ortho-McNeil, Raritan, NJ) were added to the fibro-
blast–collagen mix at a final concentration of 30 mg/ml and 100 ng/
ml, respectively. Fibroblast–collagen mixture (600 ml) was then
plated into the wells of a 24-well plate (Falcon, BD Biosciences,
Franklin Lakes, NJ), which was pre-coated with 2% BSA, and the
collagen gel was allowed to polymerize at 371C. The final fibroblast
density was 90,000 cells/well, which was determined to be optimal
for this assay (data not shown). After 2 hours incubation, the gels
were gently detached from the plastic surface to allow contraction
(Figure 9a), and 500ml of medium was added per well. The gels were
then incubated overnight at 371C in 5% CO2.
Collagen-HA composite gels. Various HA additives viz HMW
HA- (1,500 kDa, Clear Solutions Biotech Inc., Stony Brook, NY),
low MW HA- (low molecular weight HA, 190 kDa, Clear Solutions
Biotech Inc.), HA-DTPH- (Shu et al., 2002), and PEGDA- (Nektar
Therapeutics, Huntsville, AL) crosslinked HA-DTPH (HA-DTPH-
PEGDA) (Shu et al., 2004) were added to the fibroblast-populated
collagen gels. Regardless of the type, HA was added at a final
concentration of either 0.12 or 0.25% (w/v). HA-DTPH-PEGDA
hydrogel (Figure 8b) solutions were prepared in two ways: first, by
altering the crosslinking density (defined as the moles -SH on HA-
DTPH: moles -C¼C- on PEGDAH 2:1, 6:1, and 12:1) while keeping
the PEGDA MW fixed at 3400 Da, and second, by altering the
PEGDA MW (258, 700, and 3400 Da) while keeping the crosslinking
density fixed at 2:1. Typically, four volumes of the appropriate
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Figure 8. Thiol functionalized HA derivatives added to collagen gels. (a) Chemical structure of HA-DTPH and (b) chemical structure of PEGDA-crosslinked
HA-DTPH hydrogel.
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Figure 9. Schematic of the collagen gel contraction assay.
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HA-DTPH stock solution (in serum-free DMEM, pH 7.4) were added
to one volume of corresponding PEGDA stock solution (in
phosphate-buffered saline, pH 7.4) and the solutions mixed for
30 seconds at room temperature. Under these conditions, the
gelation time for the various HA-DTPH-PEGDA solutions increases
with decrease in crosslinking density, while being independent of
the PEGDA MW (Shu et al., 2004; Ghosh et al., 2005). These pre-
gelling solutions were quickly added to the fibroblast-populated
collagen solution and the final fibroblast/HA-collagen mix plated
into the wells of a 24-well plate. HA-free collagen gels were always
used as controls. Wherever appropriate, gel contraction was
monitored temporally.
Immunofluorescence staining
Fibroblast-populated collagen or collagen/HA-DTPH (0.25%)-PEG-
DA (2:1) composite gels were allowed to contract for 4 or 24 hours
post-stimulation with 5% fetal bovine serum. At the end of each time
point, samples were fixed with 3.7% formaldehyde and permeabi-
lized with a mild detergent, 1% Nonidet-P40 (Sigma). Cellular
F-actin was then stained with a 1:100 dilution of Alexa Fluor-488
labeled phalloidin (Molecular Probes; Invitrogen Corporation,
Carlsbad, CA), whereas DAPI (300 nM, Molecular Probes) was used
to stain nuclei. Images were acquired with a MetaMorph software
(Molecular Devices, Sunnyvale, CA) using 20 objective of a wide-
field fluorescent microscope (Nikon diaphot TMD).
HA in solution
The amount of HA in the supernatant of contracted collagen-HA gels
was quantified using a competitive binding HA-ELISA kit (Echelon
Biosciences, Salt Lake City, UT). In this inverse colorimetric assay, a
lower absorbance value indicates a higher quantity of HA. As higher
amounts of HA would result in values very close to the zero reading
and hence prone to errors, all samples were used at 1:10 and 1:100
dilutions. Samples to be assayed were first mixed with the detector,
and then added to the HA-ELISA plate for competitive binding. An
enzyme-linked antibody and colorimetric detection was then used to
detect the HA detector bound to the plate. The concentration of HA
in the sample was determined using a standard curve generated
using known amounts of HA.
Statistics
All collagen-HA composite assays were performed in triplicate
(n¼ 3) and the data for the area of the contracted gels was
represented as mean7SD for each experiment. The data shown
are representative of additional experiments performed. Results
were compared using the Kruskal–Wallis test (for non-parametric
independent group comparisons). The Analyse-it statistical software
was used for analysis. The level of significance was assigned at
Po0.05.
Contraction index
The contraction index of experimental gels was calculated as:
contraction index ¼ ðA0  A1ÞE  ðA0  A1ÞCðA0  A1ÞC
where (A0A1)E¼ difference between initial area (t¼ 0) and final
area (t¼ 48 hours) of experimental (A0A1)C¼ difference between
initial area (t¼ 0) and final area (t¼ 48 hours) of control.
The difference between the initial and final areas of the control
was used to normalize the experimental data. The SD of the control
was ignored for these calculations. As the initial area A0 was the
same for both the control and the experimental conditions, using the
formula described above, the experimental conditions that con-
tracted more than the control would yield a positive contraction
index and experimental conditions that contracted less than the
control would yield a negative contraction index.
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
Financial support to R.A.F.C. (NIH Grant No. AG010143) and G.D.P (NIH
Grant No. DC004336 and Centers of Excellence Program, State of Utah) is
gratefully acknowledged.
REFERENCES
Anseth KS, Bowman CN, BrannonPeppas L (1996) Mechanical properties of
hydrogels and their experimental determination. Biomaterials
17:1647–57
Bell E, Ivarsson B, Merrill C (1979) Production of a tissue-like structure
by contraction of collagen lattices by human fibroblasts of
different proliferative potential in vitro. Proc Natl Acad Sci USA
76:1274–8
Bell E, Sher S, Hull B, Merrill C, Rosen S, Chamson A et al. (1983) The
reconstitution of living skin. J Invest Dermatol 81(Suppl):2s–10s
Brecht M, Mayer U, Schlosser E, Prehm P (1986) Increased hyaluronate
synthesis is required for fibroblast detachment and mitosis. Biochem J
239:445–50
Burd DA, Siebert JW, Ehrlich HP, Garg HG (1989) Human skin and post-burn
scar hyaluronan: demonstration of the association with collagen and
other proteins. Matrix 9:322–7
Camenisch TD, McDonald JA (2000) Hyaluronan is bigger better? Am J Respir
Cell Mol Biol 23:431–3
Chen WYJ, Abatangelo G (1999) Functions of hyaluronan in wound repair.
Wound Rep Regen 7:79–89
Gabbiani G (2003) The myofibroblast in wound healing and fibrocontractive
diseases. J Pathol 200:500–3
Gabbiani G, Le Lous M, Bailey AJ, Basin S, Delaunay A (1976) Collagen and
myofibroblasts of granulation tissue. A chemical, ultrastructural and
immunologic study. Virchows Arch B 21:133–45
Gabbiani G, Ryan GB, Majno G (1971) Presence of modified fibroblasts in
granulation tissue and their possible role in wound contraction.
Experientia 27:549–50
Ghosh K, Ren X-D, Shu XZ, Prestwich GD, Clark RAF (2006) Fibronectin
functional domains coupled to hyaluronan stimulate adult human
dermal fibroblast responses critical for wound healing. Tissue Eng
12:601–13
Ghosh K, Shu XZ, Mou R, Lombardi J, Rafailovich M, Prestwich GD et al.
(2005) Rheological characterization of in situ crosslinkable hyaluronan
hydrogels. Biomacromolecules 6:2857–65
Gribbon P, Hardingham TE (1998) Macromolecular diffusion of biological
polymers measured by confocal fluorescence recovery after photo-
bleaching. Biophys J 75:1032–9
Gribbon P, Heng BC, Hardingham TE (1999) The molecular basis of the
solution properties of hyaluronan investigated by confocal fluorescence
recovery after photobleaching. Biophys J 77:2210–6
Gribbon P, Heng BC, Hardingham TE (2000) The analysis of intermolecular
interactions in concentrated hyaluronan solutions suggest no evidence
for chain–chain association. Biochem J 350:329–35
Grinnell F (1994) Fibroblasts, myofibroblasts, and wound contraction. J Cell
Biol 124:401–4
2208 Journal of Investigative Dermatology (2006), Volume 126
TD Mehra et al.
Crosslinked HA Inhibits Collagen Contraction
Grinnell F (2003) Fibroblast biology in three-dimensional collagen matrices.
Trends Cell Biol 13:264–9
Hardingham TE (1981) Proteoglycans: their structure, interactions and
molecular organisation in cartilage. Biochem Soc Trans 9:489–97
Hardingham TE, Fosang AJ (1992) Proteoglycans: many forms and many
functions. FASEB J 6:861–70
Liu Y, Shu XZ, Prestwich GD (2005) Biocompatibility and stability of
disulfide-crosslinked hyaluronan films. Biomaterials 26:4737–46
Longaker MT, Chiu ES, Harrison MR, Crombleholme TM, Langer JC, Duncan
BW et al. (1989) Studies in fetal wound healing. IV. Hyaluronic acid-
stimulating activity distinguishes fetal wound fluid from adult wound
fluid. Ann Surg 210:667–72
Longaker MT, Adzick NS, Hall JL, Stair SE, Crombleholme TM, Duncan BW
et al. (1990) Studies in fetal wound healing, VII. Fetal wound healing
may be modulated by hyaluronic acid stimulating activity in amniotic
fluid. J Pediatr Surg 25:430–3
Longaker MT, Chiu ES, Adzick NS, Stern M, Harrison MR, Stern R (1991)
Studies in fetal wound healing, V. A prolonged presence of hyaluronic
acid characterizes fetal wound healing. Ann Surg 213:292–6
Shu XZ, Liu Y, Luo Y, Roberts MC, Prestwich GD (2002) Disulfide crosslinked
hyaluronan hydrogels. Biomacromolecules 3:1304–11
Shu XZ, Liu Y, Palumbo F, Luo Y, Prestwich GD (2004) In situ crosslinkable
hyaluronan hydrogels for tissue engineering. Biomaterials 25:1339–48
Sorrell JM, Carrino DA, Baber MA, Caplan AI (1999) Versican in human fetal
skin development. Anat Embryol (Berlin) 199:45–56
Travis JA, Hughes MG, Wong JM, Wagner WD, Geary RL (2001) Hyaluronan
enhances contraction of collagen by smooth muscle cells and adventitial
fibroblasts: role of CD44 and implications for constrictive remodeling.
Circ Res 88:77–83
Yamagata M, Yamada KM, Yoneda M, Suzuki S, Kimata K (1986) Chondroitin
sulfate proteoglycan (PG-M-like proteoglycan) is involved in the binding
of hyaluronic acid to cellular fibronectin. J Biol Chem 261:13526–35
www.jidonline.org 2209
TD Mehra et al.
Crosslinked HA Inhibits Collagen Contraction
